The company’s earnings could be contributed to an unfavorable change in foreign currency exchange rates and by the sales of non-core product lines in the prior year. The company experienced a net loss of $7.7 million, a decrease from last year’s third quarter loss of $11.4 million. The net loss is attributable to non-recurring integration charges and ongoing restructuring and acquisitions.
The company reported $78.16 in bracing and support net sales and $14,559 in surgical implant sales. International sales were reported as $54, 960, a decrease from last year’s report of $58,588.
Read the release on DJO’s 3Q FY 2010 financial report.
Read other coverage on 3Q FY 2010 financial reports:
– MAKO Surgical Corp. Reports $12M in 3Q Revenue, Up 79%
– ArthroCare Total Revenue Increases by 10.6% to $87.9M
– Integra LifeSciences Total Revenues Up 8.3% to $186.6M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
